/
/
/

Colinz Laboratories Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Share Price Live Stats

Empty box

No results found

Share Market Cap & Key Ratios Overview

Empty box

No results found

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Empty box

No results found

Key Highlights of Colinz Laboratories Ltd’s P&L

In 2026-03-31, Colinz Laboratories Ltd reported total revenue of ₹6.14Cr, compared with ₹6.53Cr in 2025-03-31, reflecting Colinz Laboratories Ltd turnover.

Depreciation was ₹15.63Lakh and finance costs were ₹4.66Lakh in 2026-03-31

Profit Before Tax (PBT) has been ₹68.91Lakh in 2026-03-31 as compared to ₹61.94Lakh in 2025-03-31.

Net Profit (PAT) was ₹51.45Lakh in 2026-03-31 compared with ₹49.66Lakh in 2025-03-31.

Earnings per share (EPS) were ₹2.04 in 2026-03-31, compared with ₹1.97 in 2025-03-31.